Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » CLXN.... (Page 2)

 - UBBFriend: Email this page to someone!   This topic comprises 2 pages: 1  2   
Author Topic: CLXN....
RatBoy
Member


Member Rated:
5
Icon 1 posted      Profile for RatBoy     Send New Private Message       Edit/Delete Post   Reply With Quote 
Agreement Paves the Way for Cashless Close Expected Within the Next 10 Days
MURRIETA, CA -- (Marketwire) -- 11/06/08 -- CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today announced the signing of an amendment to its agreement to purchase the ThyroTest® product, which will allow CLX to close the acquisition through the issuance of preferred stock and a note in the amount of $750,000.

ThyroTest® is a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease. CLX entered into a definitive agreement with ThyroTec, LLC, the developer of the ThyroTest® device, on September 8, 2008.

ThyroTest® is FDA cleared and has also achieved CLIA waived status, so the test can be administered in the more than 100,000 CLIA waived doctors' offices in the U.S., as well as in any non-waived laboratory.

Terms of the amendment to the definitive agreement include the issuance to ThyroTec of Series C Convertible Preferred Shares of CLX Medical and a note in the amount of $750,000 at 6% interest for a term of 30 months, secured by the assets of the corporation. During the period of the note or until the principal is paid in full, CLX agrees to pay to ThyroTec a royalty of 10% of net sales of the ThyroTest® product.

An escrow will be established, into which the technology, the $750,000 note and the 750,000 shares of Series C Preferred Shares will be deposited. The opening of the escrow will be considered the closing, which is expected to be completed by November 14, 2008.

"We are pleased to enter into this agreement, which allows CLX to close the acquisition of ThyroTest® without raising additional capital for the close," commented Vera Leonard, chief executive officer of CLX Medical. "We look forward to a fast close under the terms of this amended agreement, so we can move forward with the execution of our post-acquisition marketing and distribution plan for ThyroTest®."

To sign up to receive information by email directly from CLX Medical, Inc. when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Medical, Inc.

CLX Medical, Inc. (www.clxmedical.com) holds a 51% equity interest in Zonda, Inc. (www.zondaincusa.com), which has developed several rapid point of care tests for medical and non-medical markets, including a rapid test for chlamydia. CLX has also entered into a definitive agreement to acquire ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease. CLX Medical is focused on the successful worldwide distribution of these and any additional products it may acquire or license.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Medical, Inc. are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Medical's control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

--------------------
Its All About the Green Backs Baby$$$$$

Posts: 46 | From: Fort Hood, Texas | Registered: Nov 2008  |  IP: Logged | Report this post to a Moderator
Lockman
Member


Member Rated:
4
Icon 1 posted      Profile for Lockman     Send New Private Message       Edit/Delete Post   Reply With Quote 
http://stockcharts.com/h-sc/ui?s=CLXN&p=D&yr=1&mn=0&dy=0&id=p27914837105

--------------------
Let's Go METS!!!

Posts: 3317 | From: CT | Registered: Dec 2006  |  IP: Logged | Report this post to a Moderator
Lockman
Member


Member Rated:
4
Icon 1 posted      Profile for Lockman     Send New Private Message       Edit/Delete Post   Reply With Quote 
Just be careful on this one. Lots of shares out there, it's gonna take a lot of volume to move this. Buy .0001 sell .0002 or .0003. jmo

--------------------
Let's Go METS!!!

Posts: 3317 | From: CT | Registered: Dec 2006  |  IP: Logged | Report this post to a Moderator
RatBoy
Member


Member Rated:
5
Icon 1 posted      Profile for RatBoy     Send New Private Message       Edit/Delete Post   Reply With Quote 
New news from CLX Med.

CLX Medical, Inc. CEO Comments on Anticipated Close of Acquisition of the ThyroTest(R) Rapid Screening Device
MURRIETA, CA -- (Marketwire) -- 11/12/08 -- CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today issued a comment from Vera Leonard, chief executive officer of the company, regarding the recent disclosure that CLX expects to close the acquisition of the ThyroTest® product through the issuance of preferred stock and a note in the amount of $750,000.

ThyroTest® is a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease. ThyroTest® is FDA cleared and has also achieved CLIA waived status, so the test can be administered in the more than 100,000 CLIA waived doctors' offices in the U.S., as well as in any non-waived laboratory.

Ms. Leonard stated, "Given the current condition of U.S. financial markets and its impact on the investment community, closing the acquisition of ThyroTest® in a cashless transaction is the ideal scenario for CLX Medical. This allows us to focus immediately on the successful marketing and distribution strategy for the product rather than on capital raising efforts.

"Our first order of business will be closing negotiations that are currently underway for distribution within the United States. Then we will implement the process of acquiring CE certification so that we can begin marketing the product through our existing and new distributors in Europe. We expect the CE certification process to be a relatively fast one, since the product is already FDA cleared in the U.S. All of this activity is geared toward generating revenue as soon as possible so that we can complete the product acquisition, continue with R&D activities with regard to the chlamydia product and, most importantly, deliver value to our shareholders," she added.

CLX Medical entered into a definitive agreement with ThyroTec, LLC, the developer of the ThyroTest® device, on September 8, 2008 and announced the amendment to the definitive agreement on November 6, 2008. Terms of the amendment include the issuance to ThyroTec of Series C Convertible Preferred Shares of CLX Medical and a note in the amount of $750,000 at 6% interest for a term of 30 months, secured by the assets of the corporation. During the period of the note or until the principal is paid in full, CLX agrees to pay to ThyroTec a royalty of 10% of net sales of the ThyroTest® product.

An escrow will be established, into which the technology, the $750,000 note and the 750,000 shares of Series C Preferred Shares will be deposited. The opening of the escrow will be considered the closing, which is expected to be completed by November 14, 2008.

To sign up to receive information by email directly from CLX Medical, Inc. when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Medical, Inc.

--------------------
Its All About the Green Backs Baby$$$$$

Posts: 46 | From: Fort Hood, Texas | Registered: Nov 2008  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
i'm in on this one just waiting for news on their ThyroTest..
Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
RatBoy
Member


Member Rated:
5
Icon 1 posted      Profile for RatBoy     Send New Private Message       Edit/Delete Post   Reply With Quote 
Yea I emailed them yesterday to see when the closing was and when they expected to put the PR out. I am just sitting and waiting

--------------------
Its All About the Green Backs Baby$$$$$

Posts: 46 | From: Fort Hood, Texas | Registered: Nov 2008  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
can't wait..
Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
what i don't understand is ..that why so many sells all last week and yesterday??
Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
does anyone know what 'Series C Convertible Preferred Shares' are? i don't know this stuff, it's new to me.
Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
low volume of trading today so far, wonder what is going on ..might see a sudden jump here just maybe..
Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
RatBoy
Member


Member Rated:
5
Icon 1 posted      Profile for RatBoy     Send New Private Message       Edit/Delete Post   Reply With Quote 
not sure why so many sells maybe due to no news. Hope it jumps a little

--------------------
Its All About the Green Backs Baby$$$$$

Posts: 46 | From: Fort Hood, Texas | Registered: Nov 2008  |  IP: Logged | Report this post to a Moderator
limey
Member


Rate Member
Icon 1 posted      Profile for limey     Send New Private Message       Edit/Delete Post   Reply With Quote 
News just in today,


November 19, 2008 - 11:34 AM EST

CLX Medical, Inc. Updates Status of ThyroTest(R) Close
MURRIETA, CA -- (Marketwire) -- 11/19/08 -- CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today updated the status of the pending close of the company's acquisition of ThyroTest® through the issuance of preferred stock and a note in the amount of $750,000.

To close the transaction, an escrow is being established, into which the ThyroTest® technology, the $750,000 note and the 750,000 shares of Series C Preferred Shares will be deposited. The opening of the escrow will be considered the closing, and the company had expected to have established the escrow and deposited the note and the shares by November 14, 2008.

"The escrow has been opened, and the documents have been approved in form by both parties to the agreement and are now being transferred to the escrow holder," stated Vera Leonard, chief executive officer of CLX Medical. "The process is moving forward, and we expect to have the close completed by the end of this week."

ThyroTest® is a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease. ThyroTest® is FDA cleared and has also achieved CLIA waived status, so the test can be administered in the more than 100,000 CLIA waived doctors' offices in the U.S., as well as in any non-waived laboratory.

CLX Medical entered into a definitive agreement with ThyroTec, LLC, the developer of the ThyroTest® device, on September 8, 2008 and subsequently entered into an amendment to the definitive agreement. The amendment provided that the transaction could be closed through the issuance to ThyroTec of Series C Convertible Preferred Shares of CLX Medical and a note in the amount of $750,000 at 6% interest for a term of 30 months, secured by the assets of the corporation. During the period of the note or until the principal is paid in full, CLX agrees to pay to ThyroTec a royalty of 10% of net sales of the ThyroTest® product.

Posts: 22 | Registered: Dec 2005  |  IP: Logged | Report this post to a Moderator
RatBoy
Member


Member Rated:
5
Icon 1 posted      Profile for RatBoy     Send New Private Message       Edit/Delete Post   Reply With Quote 
Now all we need is the close and to go up in price a little then can say ITM

--------------------
Its All About the Green Backs Baby$$$$$

Posts: 46 | From: Fort Hood, Texas | Registered: Nov 2008  |  IP: Logged | Report this post to a Moderator
  This topic comprises 2 pages: 1  2   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share